Barrett & Company’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.75K | Hold |
260
| – | – | ﹤0.01% | 566 |
|
|
2025
Q1 | $3.91K | Hold |
260
| – | – | ﹤0.01% | 518 |
|
|
2024
Q4 | $4.28K | Hold |
260
| – | – | ﹤0.01% | 509 |
|
|
2024
Q3 | $6.42K | Hold |
260
| – | – | ﹤0.01% | 461 |
|
|
2024
Q2 | $6.59K | Hold |
260
| – | – | ﹤0.01% | 467 |
|
|
2024
Q1 | $6.6K | Hold |
260
| – | – | ﹤0.01% | 467 |
|
|
2023
Q4 | $5.89K | Hold |
260
| – | – | ﹤0.01% | 459 |
|
|
2023
Q3 | $4.84K | Hold |
260
| – | – | ﹤0.01% | 484 |
|
|
2023
Q2 | $6.76K | Hold |
260
| – | – | ﹤0.01% | 445 |
|
|
2023
Q1 | $7.47K | Hold |
260
| – | – | ﹤0.01% | 411 |
|
|
2022
Q4 | $7.7K | Hold |
260
| – | – | 0.01% | 405 |
|
|
2022
Q3 | $7.7K | Buy |
+260
| New | +$7.7K | 0.01% | 405 |
|